Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media
More topics under "C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media" (918,689)
C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866)
C12N 11 - Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof (12,439)
C12N 13 - Treatment of micro-organisms or enzymes with electrical or wave energy, e.g. magnetism, sonic waves (3,958)
C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
C12N 3 - Spore-forming or isolating processes (415)
C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637)
C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535)
Patents for C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media (9,992)
05/2005
05/12/2005WO2005042713A2 Quantitative multiplex methylation-specific pcr
05/12/2005WO2005042711A2 Pain-associated gene pnpg1
05/12/2005WO2005042709A2 Compositions, methods and detection technologies for reiterative oligonucleotide synthesis
05/12/2005WO2005042708A2 METHOD OF DESIGNING siRNAS FOR GENE SILENCING
05/12/2005WO2005042707A2 Taspasel 1 and methods of use
05/12/2005WO2005042706A2 Ephx2 genetic markers associated with galantamine response
05/12/2005WO2005042705A2 Short interfering rna and micro-rna compounds and methods of designing, making and using the same
05/12/2005WO2005042704A2 Differential enzymatic fragmentation
05/12/2005WO2005042703A2 Placental stem cells and uses thereof
05/12/2005WO2005042701A2 Methods to identify compounds useful for tumor sensitization to dna damage
05/12/2005WO2005042700A2 Use of hedgehog pathway inhibitors in small-cell lung cancer
05/12/2005WO2005042699A2 Modified polypeptides with therapeutic activity and methods of use
05/12/2005WO2005042698A2 T cell epitopes useful in a hepatitis c virus vaccine and as diagnostic tools and methods for identifying same
05/12/2005WO2005042697A2 Compounds, compositions and methods
05/12/2005WO2005042696A2 Apparatus receiving and aligning multiple electrode pair array and multiple treatment cell for electroporation
05/12/2005WO2005042695A2 Lipoparticles comprising proteins, methods of making, and using the same
05/12/2005WO2005042694A2 Multi-stage microbial system for continuous hydrogen production
05/12/2005WO2005042693A2 Hla-e chimeric molecule
05/12/2005WO2005042692A2 A method of inhibiting the expression of genes which mediate cellular cholesterol influx in animal cells and inhibiting the production of proteins resulting from the expression of such genes using cholesterol absorption inhibitors
05/12/2005WO2005021731A3 Soluble analyte detection and amplification
05/12/2005WO2005019432A3 A novel gene and protein associated with angiogenesis and endothelial apoptosis
05/12/2005WO2005019424A3 Retroviral vector and cell-based assay for measuring the mutation rate of retroviruses employing same
05/12/2005WO2005010152A3 Human mast cell-expressed membrane protein
05/12/2005WO2005005596A3 Characterization of the earliest stages of the severe acute respiratory syndrome (sars) virus and uses thereof
05/12/2005WO2005001021A3 Nanocarpets for trapping particulates, bacteria and spores
05/12/2005WO2004113495A3 Rna-based transcriptional regulators
05/12/2005WO2004106497A3 Imageable animal model of sars infection
05/12/2005WO2004092339A3 Modulation of muc1 mediated signal transduction
05/12/2005WO2004092324A3 Methods and compositions for detection and analysis of polynucleotides using light harvesting multichromophores
05/12/2005WO2004081183A3 In vitro dna immortalization and whole genome amplification using libraries generated from randomly fragmented dna
05/12/2005WO2004076631A3 Biologically active native biomatrix composition
05/12/2005WO2004072233A3 Hiv-specific fusion proteins and therapeutic and diagnostic methods for use
05/12/2005WO2004065544A3 Cell suspension rotating fluidic pump
05/12/2005WO2004044137A3 Modified oligomeric compounds and compositions for use in gene modulation
05/12/2005US20050101011 Serum free nutrient broth comprised of fructose for use in propagation of cells and improving recombinant and/or endogenous protein synthesis; bioreactors
05/12/2005US20050101010 Cell culture tool and method
05/12/2005US20050100934 Method for assaying protein-protein interaction
05/12/2005US20050100877 Biodegradable polymer-ligand conjugates and their uses in isolation of cellular subpolulations and in cryopreservation, culture and transplantation of cells
05/12/2005CA2544708A1 Liver cancer biomarkers
05/12/2005CA2544367A1 Compositions, methods and detection technologies for reiterative oligonucleotide synthesis
05/12/2005CA2543966A1 Angiogensis models using nestin-expressing stem cells to image nascent blood vessels
05/12/2005CA2543954A1 Method of designing sirnas for gene silencing
05/12/2005CA2543745A1 Methods of organ regeneration
05/12/2005CA2543528A1 Placental stem cells and uses thereof
05/12/2005CA2543127A1 Primate prokineticin and prokineticin receptor polypeptides, related compositions and methods
05/12/2005CA2542542A1 Method of detecting a quantity of methylation at a locus
05/12/2005CA2541856A1 Modified polypeptides with therapeutic activity and methods of use
05/12/2005CA2534236A1 Lipoparticles comprising proteins, methods of making, and using the same
05/06/2005WO2005040399A2 Methods for quantitative determination of methylation density in a dna locus
05/06/2005WO2005040357A2 Compounds and methods for fluorescent labeling
05/06/2005WO2005040356A2 Mutant p53 protein and uses thereof
05/06/2005WO2005040355A2 Tao kinase modulators and methods of use
05/06/2005WO2005040354A2 Sensitive monitor of anti-viral therapy
05/06/2005WO2005040351A2 Compositions for inducing cell growth and differentiation and methods of using same
05/06/2005WO2005040350A2 Compositions, methods, and systems for inferring canine breeds for genetic traits and verifying parentage of canine animals
05/06/2005WO2005040348A2 Method for two- and three-dimensional microassembly of patterns and structures
05/06/2005WO2005040347A2 Methods and compositions for inhibiting cell growth and proliferation
05/06/2005WO2005040346A2 Devices and methods for hematopoietic rescue or restoration
05/06/2005WO2005040343A2 Improved apparatus and method for identification of biomolecules, in particular nucleic acid sequences, proteins, and antigens and antibodies
05/06/2005WO2005040340A2 Rnai-based modification of heterochromatin
05/06/2005WO2005040339A2 Aptamers to human epidermal growth factor receptor-3
05/06/2005WO2005040338A2 Constrained alkaloid immunogens and antibodies and uses thereof
05/06/2005WO2005040337A2 METHODS FOR BINDING AGENTS TO β-AMYLOID PLAQUES
05/06/2005WO2005040335A2 A novel mutated nerve growth factor beta gene, proteins encoded thereby, and products and methods related thereto
05/06/2005WO2005040334A2 Selective lipases and methods of screening therefor
05/06/2005WO2005040333A2 Ligand-pseudoreceptor system for generation of adenoviral vectors with altered tropism
05/06/2005WO2005026314A3 Group of genes differentially expressed in peripheral blood cells and diagnostic method and assay method using the same
05/06/2005WO2005017116A3 Thermostable peroxide-driven cytochrome p450 oxygenase variants and methods of use
05/06/2005WO2005017094A3 N-acetyl compositions as adjunct therapy for treatment and prevention of cysteine/glutathione deficiency
05/06/2005WO2005007828A3 Regulation of hif protein levels via deubiquitination pathways
05/06/2005WO2004099381A3 Genetically modified yeast species and fermentation processes using genetically modified yeast
05/06/2005WO2004094622A3 Extracellular messengers
05/06/2005WO2004085612A3 Metal binding proteins
05/06/2005WO2004078933A3 Intracellular delivery of small molecules proteins and nucleic acids
05/06/2005CA2543785A1 Compositions, methods, and systems for inferring canine breeds for genetic traits and verifying parentage of canine animals
05/06/2005CA2543782A1 Method for two- and three-dimensional microassembly of patterns and structures
05/06/2005CA2543200A1 Ligand-pseudoreceptor system for generation of adenoviral vectors with altered tropism
05/06/2005CA2542526A1 Methods for quantitative determination of methylation density in a dna locus
05/06/2005CA2542064A1 Tao kinase modulators and methods of use
05/06/2005CA2536078A1 Rnai-based modification of heterochromatin
05/05/2005US20050097639 Abiotic stress tolerance protein for use as tool in generating drought resistant crop plants
05/05/2005US20050097103 Performing sequence analysis as a multipart plan storing intermediate results as a relation
05/05/2005US20050095705 Cell comprising replication-competent adenovirus vector for use as tool in generating gene therapeutic vectors; tissue directed therapy
05/05/2005US20050095615 Methods and compositions for detecting promoter activity and expressing fusion proteins
05/05/2005US20050095610 Generating nucleotide sequences markers using 3' chain terminating nucleoside triphosphates; molecular weight markers/controls
05/05/2005US20050095583 Using genetically engineered vertebrate cell comprising an artificial segment comprising a 5' untranslated region and a 3' untranslated region of a segmented negative strand RNA virus and an open reading frame of a reporter gene as indicator expression system for determining influenza infection
05/04/2005CN1612691A Methods and compositions for correction of cardiac conduction disturbances
04/2005
04/28/2005WO2005038007A2 Posh and associated proteins
04/28/2005WO2005038006A2 Chimeric metabotropic glutamate receptors and uses thereof
04/28/2005WO2005038005A2 Shc proteins as therapeutic targets in proliferative diseases
04/28/2005WO2005038004A2 Method to product para-hydroxybenzoic acid in the stem tissue of green plants by using a tissue-specific promter
04/28/2005WO2005038003A2 Compositions and methods for generation of positive and negative selection vectors
04/28/2005WO2005038002A2 Site-specific incorporation of redox active amino acids into proteins
04/28/2005WO2005038001A2 Improved transgenesis by sperm-mediated gene transfer
04/28/2005WO2005038000A2 T cell epitopes useful in mycobacterium tuberculosis vaccine and as diagnostic tools and methods for identifying same
04/28/2005WO2005037999A2 Treatment of cancer using antibodies to lrrc15
04/28/2005WO2005037998A2 Methods and compositions related to a matrix chip
04/28/2005WO2005037997A2 Competition assay for identifying modulators of quadruplex nucleic acids
04/28/2005WO2005037996A2 In vitro development of tissues and organs
04/28/2005WO2005037995A2 Use of cox-2 inhibitor to prevent t-cell anergy induced by dendritic cell therapy
1 ... 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 ... 100